RESULTS Base Case Analysis (2 Retreatments) In the base-case analysis with 2 retreatments, semaglutide 2.4 mg plus D&E incurred higher lifetime costs but generated meaningful health gains compared with D&E alone
Tapering Protocol: To mitigate this, Iyengar suggested considering a dose taper over at least 20 weeks
In conclusion, both Wegovy and Mounjaro offer promising options for individuals struggling with obesity or overweight conditions
GLP therapies are transforming metabolic care, but their full impact depends on how well we can monitor and understand patient outcomes beyond the prescription, said Neeraj Katare , Founder, Tracky
Patients are encouraged to stay hydrated, follow dietary recommendations, and ask questions to feel confident before starting their GLP-1 weight loss journey
Heavy metals: toxicity and human health effects